Skip to main content
Christian Brander

Christian Brander

IrsiCaixa AIDS Research Institute

Christian Brander obtained his PhD in immunology from the University of Bern, Switzerland, in 1994 and completed his postdoctoral training at Harvard Medical School, USA, focusing on T cell immunity to HIV. He moved to the IrsiCaixa AIDS Research Institute in Barcelona in 2008 to lead the local HIVACAT vaccine programme.

Christian is a co-inventor of the HIV “HTI” immunogen, which is developed clinically by Aelix Therapeutics Inc., where he is a co-founder and Chief Scientific Officer. He serves as a curator of the Los Alamos HIV Immunology database and as the scientific director of the HIVACAT program, the Catalan project for the development of effective preventive and therapeutic HIV vaccines, which unites 60 investigators at two HIV research centers in Barcelona, IrsiCaixa and Hospital Clinic. He holds Associate Professor positions at the University of Vic, Central Catalonia and the Autonomous University of Barcelona.

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.